Pharsight

ACTELION PHARMACEUTICALS PATENTS FACING OPPOSITIONS

Top patents of ACTELION PHARMACEUTICALS facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2315587B1 25 Oct, 2017 Therapeutic Compositions Containing Macitentan NA 5
EP3300729B1 09 Oct, 2019 Therapeutic Compositions Containing Macitentan NA 3
EP3256125B1 26 Jan, 2022 Dosing Regimen For A Selective S1P1 Receptor Agonist Dec, 2035 2
EP3592391B1 21 Apr, 2021 Pharmaceutical Composition Comprising Selexipag Mar, 2038 1